AAT Prolastin Market Size and Forecast The Alpha-1 Antitrypsin Deficiency (AATD) Augmentation Therapy Market, of which Prolastin is a key component, was valued at approximately USD 1.63 billion in 2024. This market…
VWD Humate-P Market: Size, Forecast, Drivers, and Key Trends
VWD Humate-P Market Size and Forecast The Von Willebrand Disease (VWD) market, where Humate-P is a key therapy, is showing steady expansion due to improved diagnosis and treatment accessibility. Humate-P is a…
Emi for Acquired Market: Size, Forecast, Drivers, and Key Trends
Enterprise Manufacturing Intelligence (EMI) Market Size and Forecast The global Enterprise Manufacturing Intelligence (EMI) market is witnessing significant expansion as industries prioritize digital transformation and operational efficiency. EMI systems are crucial for…
FVIII Adynovate Market: Size, Forecast, Drivers, and Key Trends
Adynovate Market Size and Forecast Adynovate (pegylated recombinant Factor VIII) is a key player in the Hemophilia A therapeutics market, offering an extended half-life solution that reduces dosing frequency compared to standard…
Behc Infliximab Market: Size, Forecast, Drivers, and Key Trends
Behçet’s Syndrome Infliximab Market Size and Forecast The market for Infliximab in Behçet’s Syndrome (BS) is a niche segment within the broader rheumatology and biologics markets. It focuses on treating severe, refractory…
Sjog Efgartigimod Market: Size, Forecast, Drivers, and Key Trends
Efgartigimod Market Size and Forecast Efgartigimod, marketed as Vyvgart, is an IgG1 Fc fragment approved for generalized Myasthenia Gravis (gMG). Its market size was estimated at approximately USD 2.19 billion in 2024….
Viti Levo Rux Market: Size, Forecast, Drivers, and Key Trends
Viti Levo Rux Market Size and Forecast The Viti Levo Rux market, specializing in next-generation therapeutic compounds, is poised for significant expansion, driven by its application in complex disease management. Current market…
PsA Skyrizi Market: Size, Forecast, Drivers, and Key Trends
PsA Skyrizi Market Size and Forecast Skyrizi (risankizumab), an interleukin-23 (IL-23) inhibitor developed by AbbVie, has secured a significant position in the Psoriatic Arthritis (PsA) treatment landscape. The drug’s market performance is…
CD Skyrizi Market: Size, Forecast, Drivers, and Key Trends
Skyrizi (Crohn’s Disease) Market Size and Forecast Skyrizi (risankizumab), an IL-23 inhibitor developed by AbbVie, is a major growth driver in the inflammatory bowel disease (IBD) market, particularly for Crohn’s disease (CD)….
UC Upadacitinib Market: Size, Forecast, Drivers, and Key Trends
UC Upadacitinib Market Size and Forecast Upadacitinib, marketed as RINVOQ, is a Janus kinase (JAK) inhibitor approved for various inflammatory conditions, including Ulcerative Colitis (UC). The drug has quickly secured a notable…